Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
IRVINE, Calif., March 30 /PRNewswire-FirstCall/ -- IntraLase Corp. (NASDAQ:ILSE) announced today that its stockholders have approved the merger with Advanced Medical Optics, Inc. (NYSE:EYE). A...
Laser Sales Up 31%, Procedure Volumes Up 54% in 2006; 574 Lasers Now Installed Worldwide IRVINE, Calif., March 1 /PRNewswire-FirstCall/ -- IntraLase Corp. (NASDAQ:ILSE) today reported revenues...
Obtains Ownership of Licensed Intellectual Property IRVINE, Calif., Feb. 28 /PRNewswire-FirstCall/ -- IntraLase Corp. (NASDAQ:ILSE), manufacturer of the ultra-fast laser that is revolutionizing...
SANTA ANA, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE:EYE), a global ophthalmic surgical and eye care products company, and IntraLase Corp. (NASDAQ:ILSE...
Contract Award Across All Branches of U.S. Military Firmly Establishes IntraLase as LASIK Technology of Choice IRVINE, Calif., Dec. 22 /PRNewswire-FirstCall/ -- IntraLase Corp. (NASDAQ:ILSE...
- For the First Time in the United States, LASIK and Military Aviation Come Together as Groundbreaking Bureau of Naval Medicine Project Opens Door for Previously Ineligible Naval Aviators...
IRVINE, Calif., Dec. 5 /PRNewswire-FirstCall/ -- IntraLase Corp. (NASDAQ:ILSE), manufacturer of the ultra-fast laser that is revolutionizing refractive and corneal surgery, today announced that...
Dr. Dello Russo Is One of the First Surgeons in the Nation to Offer Blade-Free LASIK With the IntraLase Method NEW YORK, Nov. 28 /PRNewswire-FirstCall/ -- Dr. Joseph Dello Russo of LaserVision...
IRVINE, Calif., Nov. 21 /PRNewswire-FirstCall/ -- IntraLase Corp. (NASDAQ:ILSE), manufacturer of the ultra-fast laser that is revolutionizing refractive and corneal surgery, today announced that...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
